GLG

Debtsy is building and enforcing trust in consumer finance. Borrowers in delinquency and default face harassment, hidden fees, and harmed credit scores. Creditors lose out on recoveries, expose themselves to compliance and operational risks, and compromise the trust on which their relationships with borrowers are built. Debtsy is designed from the ground up to utilize technology to provide a more streamlined, compliant, and effective resolution process for borrowers and creditors alike.

Imbellus, Inc., established in 2015 and based in Los Angeles, California, specializes in developing simulation-based cognitive assessments aimed at measuring how individuals think rather than what they know. In an era increasingly influenced by automation, Imbellus focuses on equipping students with the deep thinking skills essential for modern work and life, proposing to replace traditional standardized tests such as the SAT and ACT. The company collaborates with corporate and government entities to enhance their hiring, upskilling, and retention strategies. With a diverse team comprising learning scientists, game developers, artists, data scientists, and AI engineers, Imbellus has secured $23 million in venture capital funding to support its innovative approach to competency measurement and assessment.

CoVenture is a New York-based private equity firm established in 2011 that focuses on investing in technology through various strategies. The firm targets pre-seed and early-stage companies across the United States, leveraging its unique capital base to engage in special situations and emerging assets. CoVenture manages multiple venture debt funds, including the No1 Credit Opportunities Fund and the Special Opportunities Fund, which provide alternative direct credit opportunities to support early-stage technology ventures.

Celmatix is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead program in ovarian senescence and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health.

Ushi is a private business social networking platform connecting China's influential professionals and entrepreneurs via mobile phones and PCs. Ushi makes it easier to find new customers, partners, employees, jobs, and experts, and enables members to share and discuss information. 优士 (yōushì) means 'outstanding professionals' in Chinese, with a double meaning of 'competitive advantange'. Ushi is focused on helping its members to expand and maximize the value of their professional networks, to achieve greater success. Shanghai-based Ushi was founded by 100 Charter Members who are successful business leaders in China, including partners of the most famous VC firms, investment banks, law firms, and accounting firms, as well as CEOs of advertising agencies, luxury brands, and leading companies in Internet, mobile, renewable energy, travel, hotel, real estate and other industries. As such, Ushi aims to be China's top platform for business networking, featuring the highest quality community and opening up the highest quality opportunities for members. http://www.Ushi.com

Kyruus, Inc. develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010 and headquartered in Boston, Massachusetts, the company offers a range of analytically driven tools designed to enhance the engagement and management of large physician networks. Key products include Kyruus Passport, which tracks physician productivity and performance, and Kyruus Profiles, which provides administrators with insights into physician activity. Additionally, Kyruus MDSeekyr helps users identify high-value providers, while Kyruus Insight Reports enables executives to analyze physician network performance over time. The company's ProviderMatch suite further enhances patient-provider matching and streamlines the scheduling process, ensuring a consistent patient experience across various access points. By leveraging big data, Kyruus aims to align provider supply with patient demand effectively.